Squamous Cell Esophagus Cancer
1 clinical trials · Condition
◉ Watch Squamous Cell Esophagus Cancer
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab in Refractory Advanced Esophageal Cancer (NCT02971956) | Dana-Farber Cancer Institute | 2017-01-18 |
Track Squamous Cell Esophagus Cancer automatically
Every clearance here is in the API, with alerts when new ones post.